Free Trial

Arkema (OTCMKTS:ARKAY) Posts Earnings Results, Misses Expectations By $0.33 EPS

Arkema logo with Basic Materials background
Remove Ads

Arkema (OTCMKTS:ARKAY - Get Free Report) issued its quarterly earnings data on Thursday. The basic materials company reported $1.35 EPS for the quarter, missing the consensus estimate of $1.68 by ($0.33), Zacks reports. Arkema had a return on equity of 8.04% and a net margin of 3.82%. The business had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.50 billion.

Arkema Stock Down 1.3 %

Shares of OTCMKTS:ARKAY traded down $1.08 during trading on Monday, hitting $81.20. 3,115 shares of the company's stock traded hands, compared to its average volume of 14,438. The company has a 50-day moving average price of $79.30 and a 200-day moving average price of $84.25. Arkema has a 52 week low of $71.26 and a 52 week high of $111.79. The company has a current ratio of 2.11, a quick ratio of 1.54 and a debt-to-equity ratio of 0.48. The company has a market cap of $6.18 billion, a price-to-earnings ratio of 16.24, a price-to-earnings-growth ratio of 0.53 and a beta of 1.22.

About Arkema

(Get Free Report)

Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.

See Also

Earnings History for Arkema (OTCMKTS:ARKAY)

Should You Invest $1,000 in Arkema Right Now?

Before you consider Arkema, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.

While Arkema currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads